FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

734149006: Product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3709303019 Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3709304013 Product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Is a Product containing emtricitabine and tenofovir in oral dose form (medicinal product form) true Inferred relationship Some
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Is a Cobicistat-containing product in oral dose form true Inferred relationship Some
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Is a Elvitegravir-containing product in oral dose form true Inferred relationship Some
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Is a Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product) true Inferred relationship Some
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Has active ingredient Emtricitabine (substance) true Inferred relationship Some 1
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Has active ingredient Tenofovir (substance) true Inferred relationship Some 2
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Has active ingredient Elvitegravir (substance) true Inferred relationship Some 3
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Has active ingredient Cobicistat true Inferred relationship Some 4
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Has manufactured dose form Oral dose form true Inferred relationship Some
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Plays role Antiretroviral therapeutic role false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Is a False Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Inferred relationship Some
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) Is a True Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start